Sensorineural hearing loss: An underdiagnosed complication of Kawasaki disease

Journal of Clinical Rheumatology

Volumn 16, Issue 7, 2010, Pages 322-325

  Magalhães, Cristina M R ^a,b   Magalhães Alves, Natália R ^a   Oliveira, Karina Maria A ^b   Silva, Isabella M C ^c   Gandolfi, Lenora ^a   Pratesi, Riccardo ^a  

^a UNIVERSITY OF BRASILIA   (Brazil)

^b Federal District School of Health Sciences   (Brazil)

^c Department of Phonoaudiology   (Brazil)

Author keywords

auditory brainstem evoked responses; intravenous administration of immunoglobulin; Kawasaki disease; sensorineural hearing loss

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN;

ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ARTERY ANEURYSM; ERYTHROCYTE SEDIMENTATION RATE; EVOKED BRAIN STEM AUDITORY RESPONSE; FEMALE; HEARING LOSS; HUMAN; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; ONSET AGE; OTOACOUSTIC EMISSION; PERCEPTION DEAFNESS; PREVALENCE; PRIORITY JOURNAL; SYSTEMIC VASCULITIS; THROMBOCYTOSIS;

AUDIOMETRY; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEARING LOSS, SENSORINEURAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; INFANT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PREVALENCE; TIME FACTORS;

EID: 78049316678     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181f603bc     Document Type: Article

References (28)

1. Burns JC, Glodé MP. Kawasaki syndrome. Lancet 2004;364:533-544.
2. Rowley AH, Baker SC, Orenstein JM, et al. Searching for the cause of Kawasaki disease-cytoplasm inclusion bodies provides new insights. Nat Rev Microbiol 2008;6:395-401.
3. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-1733. (Pubitemid 41754943)
4. Rowley AH, Shulman ST. Kawasaki syndrome. Clin Microbiol Rev 1998;11(3):405-414.
5. Kato H, Sugimura T, Akagi T, et al. Long-term consequences of Kawasaki disease. A 10-to 21 year follow up study of 594 patients. Circulation 1996;94:1379-1385.
6. Liberthson RR. Sudden death from cardiac cause in children and young adults. N Engl J of Med 2006;334:1039-1044.
7. Nakamura Y, Yanagawa H, Harada K, et al. Mortality among persons with a history of Kawasaki disease in Japan: existence of cardiac sequelae elevated the mortality. J Epidemiol 2000;10:372-375.
8. Bushara K, Wilson A, Rust RS. Facial palsy in Kawasaki syndrome. Pediatr Neurol 1997;17:362-364.
9. Poon LKH, Lun KS, Ng YM. Facial nerve palsy and Kawasaki disease. Hong Kong Med J 2000;6:224-226.
10. King JW, Schlieper A, Birdi N, et al. The effect of Kawasaki disease in cognition and behavior. Arch. Pediatr Adolesc Med 2000;154: 463-468.
11. Ohno S, Miyajima T, Higuchi M, et al. Ocular manifestations of Kawasaki disease (mucocutaneous lymphonode syndrome). Am J Ophthalmol 1982;93:713-717.
12. Sundel RP, Cleveland SS, Bener AS, et al. Audiologic profiles of children with Kawasaki disease. Am J Otol 1992;13:512-515.
13. Knott PD, Orloff LA, Harris JP, et al. Sensorineural hearing loss associated and Kawasaki disease: a prospective study. Am J Otolaryngol 2001;22:343-348.
14. Nadol JB. Hearing loss. N Engl J Med 1993;329:1092-1102.
15. Chiappa KH. Evoked Potentials in Clinical Medicine. 2nd ed. New York: Raven Press; 1989.
16. Ravekes WJ, Colan SD, Kimberlee G, et al. Aortic root dilation in Kawasaki disease. Am J Cardiol 2001;87:919-922.
17. Iemura M, Ishii M, Sugimura T, et al. Long term consequences of regressed coronary aneurysms after Kawasaki disease: vascular Wall morphology and function. Heart 2000;83:307-311.
18. Silva CHM, Roscoe ICRG, Fernades KP, et al. Sensorineural hearing loss associated to Kawasaki disease. J Pediatr (Rio J) 2002; 78:71-74.
19. Kara A, Besbas N, Tezer H, et al. Reversible sensorineural hearing loss in a girl with Kawasaki disease. Turk J Pediatr 2007;49:431-433.
20. Lloyd AJ, Walker C, Wilkinso M. Kawasaki disease: is it caused by an infections agent? Br J Biomed Sci 2001;58:122-128.
21. Rowley AH, Shulman ST. New developments in the search for the etiologic agent of Kawasaki disease. Curr Opin Pediatr 2007;19:71-74.
22. Burgner D, Harnden A. Kawasaki disease: what is the epidemiology telling us about the etiology? Int J Infect Dis 2005;9:185-194.
23. Cimaz R, Falcini F. An update on Kawasaki disease. Autoimmun Rev 2003;2:258-263.
24. Leung DY, Schlievert PM, Meissner HC. The immunopathogenesis and management of Kawasaki syndrome. Arthritis Rheum 1998;41:538-547.
25. Harris JP. Immunologic mechanisms in disorders of inner ear. In: Cummings CW, ed. Otolaryngology: Head and Neck Surgery. St Louis, MO: CV Mosby; 1986;43:572-574.
26. Pagnoux C, Guillevin L. Peripheral neuropathy in systemic vasculitides. Curr Opin Rheumatol 2005;17:41-48.
27. Huang Z, Luo Y, Wu Z, et al. Paradoxical enhancement of active cochlear mechanics in long-term administration of salicylate. J Neurophysiol 2005;93:2053-2061.
28. Cazals Y. Auditory sensori-neural alterations induced by salicylate. Prog Neurobiol 2000;62:583-631.